Sensei Biotherapeutics stockholders reelect all three director nominees at 2024 annual meeting

Sensei Biotherapeutics, Inc.

Elected directors Jessie English, James Peyer, Thomas Ricks; each received ~9-10M votes for, ~0.8-1.9M withheld.
Ratified Deloitte & Touche as independent auditor for FY 2024 with 16.3M for, 0.8M against, 17k abstentions.
Approximately 68.2% of outstanding shares (17.1M of 25.1M) were present or represented at the meeting.
Broker non-votes on director election totaled ~6.1M for each nominee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.